Skip to content
RASFFReference 2022.0806

Ashwagandha is marketed to the Danish consumers

Official information organised for easier consultation. The source publication remains authoritative.

RASFF

Identification and classification

Reference
2022.0806
Notification ID
531276
Classification
information notification for follow-up
Risk decision
undecided
Product type
food
Notification basis
official control on the market
Status
ec_validated

RASFF

Product

Description
Herboxa Ashwagandha, Herboxa Shilajit og Herboxa Slim Sleep
Distribution status
Description
product traded online
Notification ID
228
Notification ID
12239786
Category
Description
dietetic foods, food supplements and fortified foods
Notification ID
18439

RASFF

Risk and analytical results

Notification ID
62693

RASFF

Origin, notification and distribution

Origin
Germany
Notifying country or territory
Denmark
Published distribution
product traded online

RASFF

Published territorial roles

  1. Roles
    1. Role
      NOTIFYING
      notificationId
      531276
    Organisation
    code
    DK
    countryNetworkOrganizationId
    5008
    Description
    Denmark
    Notification ID
    53
  2. Roles
    1. Role
      ORIGIN
      notificationId
      531276
    2. Role
      OPERATOR
      notificationId
      531276
    Organisation
    code
    DE
    countryNetworkOrganizationId
    5007
    Description
    Germany
    Notification ID
    3

RASFF

Follow-ups

  1. fupDate
    18-02-2022 15:00:07
    fupId
    532470
    fupNumber
    1
    fupType
    Description
    notification upgrade
    Notification ID
    27667
    networkOrganizationId
    53
    organizationCode
    DK
    organizationDescription
    Denmark

RASFF

5007
  1. countryNetworkOrganizationId
    5007
    Notification ID
    16
    link
    http://www.lebensmittelwarnung.de
5008
  1. countryNetworkOrganizationId
    5008
    Notification ID
    10

Provenance and context

NagameAlert organises public RASFF data while preserving official values and keeping notification classification separate from the risk decision. The official record remains authoritative and should be checked for follow-ups and current status.